Why the study?
Does a comprehensive ARF/RHD control program improve health outcomes and reduce costs compared to doing nothing in children and young adults?
Does a comprehensive ARF/RHD control program improve health outcomes and reduce costs compared to doing nothing in children and young adults?
A comprehensive 10-year program to control acute rheumatic fever and rheumatic heart disease in Cuba was cost-saving and dramatically reduced morbidity and premature mortality.
No takes yet. Share an insight, caveat, or question.
May support ARF/RHD programs in endemic settings; extends Level 4 cost-effectiveness data but leaves open randomized confirmation.
Watkins et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: